Skip to main content
Top
Gepubliceerd in: Quality of Life Research 8/2018

09-02-2018 | Review

Systematic review of quality of life in Turner syndrome

Auteurs: Carolina Trombeta Reis, Maíra Seabra de Assumpção, Gil Guerra-Junior, Sofia Helena Valente de Lemos-Marini

Gepubliceerd in: Quality of Life Research | Uitgave 8/2018

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

This study aimed to systematically review the available literature on “quality of life” (QoL) or “health-related quality of life” (HRQoL) in Turner syndrome (TS) patients and to analyze the relations among height, puberty, and the use of growth hormone (GH) and the QoL of TS patients.

Methods

An electronic bibliographic search was conducted through the PubMed, Embase, Bireme, Scopus, and Web of Science databases. The main terms were “Quality of Life” and “Turner syndrome.”

Results

Among the databases, 559 articles were found; after the selection process, 13 studies were selected. A quality assessment was conducted, and all the studies were of high quality. Eight well-known QoL questionnaires were used, and the selected studies presented factors that may be related to the QoL of TS patients, such as height, puberty, and GH use. However, a more detailed understanding of which factors are associated with the QoL of TS patients is still needed, which may be due to the lack of specific QoL instruments involving important aspects related to TS.

Conclusion

The QoL of TS patients appears to be compromised, but existing data regarding the relations among height, puberty, and GH and QoL are still controversial. Although these factors should be carefully considered in TS patients, it was not possible to determine whether they have a significant relation with the QoL of TS patients.
Literatuur
2.
go back to reference Jacobs, P., Dalton, P., James, R., Mosse, K., Power, M., & Robinson, D. (1997). Turner syndrome: A cytogenetic and molecular study. Annals of Human Genetics, 61, 471–483.CrossRefPubMed Jacobs, P., Dalton, P., James, R., Mosse, K., Power, M., & Robinson, D. (1997). Turner syndrome: A cytogenetic and molecular study. Annals of Human Genetics, 61, 471–483.CrossRefPubMed
3.
go back to reference Nielsen, J., & Wohlert, M. (1990). Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Original Article Series, 26(4), 209–223.PubMed Nielsen, J., & Wohlert, M. (1990). Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Original Article Series, 26(4), 209–223.PubMed
4.
go back to reference Sybert, V. P., & McCauley, E. (2004). Turner’s syndrome. New England Journal of Medicine, 351, 1227–1238.CrossRefPubMed Sybert, V. P., & McCauley, E. (2004). Turner’s syndrome. New England Journal of Medicine, 351, 1227–1238.CrossRefPubMed
5.
go back to reference Bondy, C. A. (2006). Turner’s syndrome and X chromosome - based differences in disease susceptibility. Gender Medicine, 3(1), 18–30.CrossRefPubMed Bondy, C. A. (2006). Turner’s syndrome and X chromosome - based differences in disease susceptibility. Gender Medicine, 3(1), 18–30.CrossRefPubMed
6.
go back to reference Donaldson, M. D. C., Gault, E. J., Tan, K. W., & Dunger, D. B. (2006). Optimising management in Turner syndrome: from infancy to adult transfer. Archives of Disease in Childhood, 91, 513–520.CrossRefPubMedPubMedCentral Donaldson, M. D. C., Gault, E. J., Tan, K. W., & Dunger, D. B. (2006). Optimising management in Turner syndrome: from infancy to adult transfer. Archives of Disease in Childhood, 91, 513–520.CrossRefPubMedPubMedCentral
7.
go back to reference Power, T., Langlois, N. E. I., & Byard, R. W. (2014). The forensic implications of Turner’s syndrome. Journal of Forensic Sciences, 59(3), 671–675.CrossRefPubMed Power, T., Langlois, N. E. I., & Byard, R. W. (2014). The forensic implications of Turner’s syndrome. Journal of Forensic Sciences, 59(3), 671–675.CrossRefPubMed
8.
go back to reference Wang, S., Yang, L., Li, J., & Mu, Y. (2015). Concurrent insulinoma with mosaic Turner syndrome: A case report. Experimental and Therapeutic Medicine, 9, 801–804.CrossRefPubMedPubMedCentral Wang, S., Yang, L., Li, J., & Mu, Y. (2015). Concurrent insulinoma with mosaic Turner syndrome: A case report. Experimental and Therapeutic Medicine, 9, 801–804.CrossRefPubMedPubMedCentral
9.
go back to reference Gawlik, A., & Malecka-Tendera, E. (2014). Treatment of Turner’s syndrome during transition. European Journal of Endocrinology, 170, R57-R74.CrossRef Gawlik, A., & Malecka-Tendera, E. (2014). Treatment of Turner’s syndrome during transition. European Journal of Endocrinology, 170, R57-R74.CrossRef
10.
go back to reference Giordano, R., Forno, D., Lanfranco, F., Manieri, C., Ghizzoni, L., & Ghigo, E. (2011). Metabolic and cardiovascular outcomes in a group of adult patients with Turner’s syndrome under hormonal replacement therapy. European Journal of Endocrinology, 164, 819–826.CrossRefPubMed Giordano, R., Forno, D., Lanfranco, F., Manieri, C., Ghizzoni, L., & Ghigo, E. (2011). Metabolic and cardiovascular outcomes in a group of adult patients with Turner’s syndrome under hormonal replacement therapy. European Journal of Endocrinology, 164, 819–826.CrossRefPubMed
11.
go back to reference Levitsky, L. L., Luria, A. H. O., Hayes, F. J., & Lin, A. E. (2015). Turner syndrome: Update on biology and management across the life span. Current Opinion in Endocrinology, Diabetes and Obesity, 22(1):65–72.CrossRef Levitsky, L. L., Luria, A. H. O., Hayes, F. J., & Lin, A. E. (2015). Turner syndrome: Update on biology and management across the life span. Current Opinion in Endocrinology, Diabetes and Obesity, 22(1):65–72.CrossRef
12.
go back to reference Lucaccioni, L., Wong, S. C., Smyth, A., Lyall, H., Dominiczak, A., Ahmed, S. F., et al. (2015). Turner syndrome—issues to consider for transition to adulthood. British Medical Bulletin, 113, 45–58.CrossRefPubMed Lucaccioni, L., Wong, S. C., Smyth, A., Lyall, H., Dominiczak, A., Ahmed, S. F., et al. (2015). Turner syndrome—issues to consider for transition to adulthood. British Medical Bulletin, 113, 45–58.CrossRefPubMed
13.
14.
go back to reference Mccauley, E., Feuillan, P., Kushner, H., & Ross, J. L. (2001). Psychosocial development in adolescents with Turner syndrome. Journal of Developmental and Behavioral Pediatrics, 22(6), 360–365.CrossRefPubMed Mccauley, E., Feuillan, P., Kushner, H., & Ross, J. L. (2001). Psychosocial development in adolescents with Turner syndrome. Journal of Developmental and Behavioral Pediatrics, 22(6), 360–365.CrossRefPubMed
15.
go back to reference Marzelli, M. J., Hoeft, F., Hong, D. S., & Reiss, A. L. (2011). Neuroanatomical spatial patterns in Turner syndrome. NeuroImage, 55, 439–447.CrossRefPubMed Marzelli, M. J., Hoeft, F., Hong, D. S., & Reiss, A. L. (2011). Neuroanatomical spatial patterns in Turner syndrome. NeuroImage, 55, 439–447.CrossRefPubMed
17.
go back to reference The WHOQOL Group. (1995). The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Social Science and Medicine, 41, 1403–1409.CrossRef The WHOQOL Group. (1995). The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Social Science and Medicine, 41, 1403–1409.CrossRef
18.
go back to reference Hoxha, P., Babameto-Laku, A., Vyshka, G., Gjoka, K., Minxuri, D., Myrtaj, E., et al. (2015). Turner syndrome in Albania and the efficacy of its treatment with growth hormone. Journal of Pediatric Endocrinology and Metabolism, 28(11–12), 1227–1234.PubMed Hoxha, P., Babameto-Laku, A., Vyshka, G., Gjoka, K., Minxuri, D., Myrtaj, E., et al. (2015). Turner syndrome in Albania and the efficacy of its treatment with growth hormone. Journal of Pediatric Endocrinology and Metabolism, 28(11–12), 1227–1234.PubMed
19.
go back to reference Fekkes, M., Kamphuis, R. P., Ottenkamp, J., Verrips, E., Vogels, T., & Kamphuis, M. (2001). Health-related quality of life in young adults with minor congenital heart disease. Psychology and Health, 16, 239–251.CrossRef Fekkes, M., Kamphuis, R. P., Ottenkamp, J., Verrips, E., Vogels, T., & Kamphuis, M. (2001). Health-related quality of life in young adults with minor congenital heart disease. Psychology and Health, 16, 239–251.CrossRef
20.
go back to reference Dołega, Z., Jeż, W., & Irzyniec, T. (2014). The cohort effect in studies related to differences in psychosocial functioning of women with Turner syndrome. Endokrynologia Polska, 65(4), 287–294.CrossRefPubMed Dołega, Z., Jeż, W., & Irzyniec, T. (2014). The cohort effect in studies related to differences in psychosocial functioning of women with Turner syndrome. Endokrynologia Polska, 65(4), 287–294.CrossRefPubMed
21.
go back to reference Ros, C., Alobid, I., Balasch, J., Mullol, J., & Castelo-Branco, C. (2013). Turner’s syndrome and other forms of congenital hypogonadism impair quality of life and sexual function. American Journal of Obstetrics and Gynecology, 208(6), 484.e1–484.e6.CrossRef Ros, C., Alobid, I., Balasch, J., Mullol, J., & Castelo-Branco, C. (2013). Turner’s syndrome and other forms of congenital hypogonadism impair quality of life and sexual function. American Journal of Obstetrics and Gynecology, 208(6), 484.e1–484.e6.CrossRef
22.
go back to reference Cardoso, G., Daly, R., Haq, N. A., Hanton, L., Rubinow, D. R., Bondy, C. A., et al. (2004). Current and lifetime psychiatric illness in women with Turner syndrome. Gynecological Endocrinology, 19(6), 313–319.CrossRefPubMed Cardoso, G., Daly, R., Haq, N. A., Hanton, L., Rubinow, D. R., Bondy, C. A., et al. (2004). Current and lifetime psychiatric illness in women with Turner syndrome. Gynecological Endocrinology, 19(6), 313–319.CrossRefPubMed
23.
go back to reference Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ, 339, b2535.CrossRefPubMedPubMedCentral Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ, 339, b2535.CrossRefPubMedPubMedCentral
26.
go back to reference Freriks, K., Verhaak, C. M., Sas, T. C. J., Menke, L. A., Wit, J. M., Otten, B. J., et al. (2015). Long-term effects of oxandrolone treatment in childhood on neurocognition, quality of life and social - emotional functioning in young adults with Turner syndrome. Hormones and Behavior, 69, 59–67.CrossRefPubMed Freriks, K., Verhaak, C. M., Sas, T. C. J., Menke, L. A., Wit, J. M., Otten, B. J., et al. (2015). Long-term effects of oxandrolone treatment in childhood on neurocognition, quality of life and social - emotional functioning in young adults with Turner syndrome. Hormones and Behavior, 69, 59–67.CrossRefPubMed
27.
go back to reference Nadeem, M., & Roche, E. F. (2014). Health-related quality of life in Turner syndrome and the influence of key features. Journal of Pediatric Endocrinology and Metabolism, 27(3–4), 283–289.PubMed Nadeem, M., & Roche, E. F. (2014). Health-related quality of life in Turner syndrome and the influence of key features. Journal of Pediatric Endocrinology and Metabolism, 27(3–4), 283–289.PubMed
28.
go back to reference Taback, S. P., & Van Vliet, G. (2011). Health-related quality of life of young adults with Turner syndrome following a long-term randomized controlled trial of recombinant human growth hormone. BMC Pediatrics, 11, 49.CrossRefPubMedPubMedCentral Taback, S. P., & Van Vliet, G. (2011). Health-related quality of life of young adults with Turner syndrome following a long-term randomized controlled trial of recombinant human growth hormone. BMC Pediatrics, 11, 49.CrossRefPubMedPubMedCentral
29.
go back to reference Lasaite, L., Lašiene, D., & Lašas, L. (2010). Cognition, emotions and quality of life in Lithuanian girls with Turner syndrome after growth hormone therapy discontinuation. Journal of Pediatric Endocrinology and Metabolism, 23(5), 443–450.CrossRefPubMed Lasaite, L., Lašiene, D., & Lašas, L. (2010). Cognition, emotions and quality of life in Lithuanian girls with Turner syndrome after growth hormone therapy discontinuation. Journal of Pediatric Endocrinology and Metabolism, 23(5), 443–450.CrossRefPubMed
30.
go back to reference Amundson, E., Boman, U. W., Barrenas, M. L., Bryman, I., & Landin-Wilhelmsen, K. (2010). Impact of growth hormone therapy on quality of life in adults with Turner syndrome. Journal of Clinical Endocrinology and Metabolism, 95, 1355–1359.CrossRefPubMed Amundson, E., Boman, U. W., Barrenas, M. L., Bryman, I., & Landin-Wilhelmsen, K. (2010). Impact of growth hormone therapy on quality of life in adults with Turner syndrome. Journal of Clinical Endocrinology and Metabolism, 95, 1355–1359.CrossRefPubMed
32.
go back to reference Zuckerman-Levin, N., Frolova-Bishara, T., Militianu, D., Levin, M., Aharon-Peretz, J., & Hochberg, Z. (2009). Androgen replacement therapy in turner syndrome: A pilot study. Journal of Clinical Endocrinology and Metabolism, 94(12), 4820–4827.CrossRefPubMed Zuckerman-Levin, N., Frolova-Bishara, T., Militianu, D., Levin, M., Aharon-Peretz, J., & Hochberg, Z. (2009). Androgen replacement therapy in turner syndrome: A pilot study. Journal of Clinical Endocrinology and Metabolism, 94(12), 4820–4827.CrossRefPubMed
33.
go back to reference Bannink, E. M., Raat, H., Mulder, P. G. H., & Keizer-schrama, S. M. P. F. M. (2006). Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome. The Journal of Pediatrics, 148, 678–684.CrossRef Bannink, E. M., Raat, H., Mulder, P. G. H., & Keizer-schrama, S. M. P. F. M. (2006). Quality of life after growth hormone therapy and induced puberty in women with Turner syndrome. The Journal of Pediatrics, 148, 678–684.CrossRef
34.
go back to reference Carel, J. C., Elie, C., Ecosse, E., Tauber, M., Léger, J., Sylvie, & Cabrol (2006). Self-esteem and social adjustment in young women with Turner syndrome- influence of pubertal management and sexuality: Population- based cohort study. Journal of Clinical Endocrinology and Metabolism, 91(80), 2972–2979.CrossRefPubMed Carel, J. C., Elie, C., Ecosse, E., Tauber, M., Léger, J., Sylvie, & Cabrol (2006). Self-esteem and social adjustment in young women with Turner syndrome- influence of pubertal management and sexuality: Population- based cohort study. Journal of Clinical Endocrinology and Metabolism, 91(80), 2972–2979.CrossRefPubMed
35.
go back to reference Carel, J. C., Ecosse, E., Bastie-Sigeac, I., Cabrol, S., Tauber, M., Leger, J., et al. (2005). Quality of life determinants in young women with Turner’s syndrome after growth hormone treatment: Results of the StaTur population-based cohort study. Journal of Clinical Endocrinology and Metabolism, 90, 1992–1997.CrossRefPubMed Carel, J. C., Ecosse, E., Bastie-Sigeac, I., Cabrol, S., Tauber, M., Leger, J., et al. (2005). Quality of life determinants in young women with Turner’s syndrome after growth hormone treatment: Results of the StaTur population-based cohort study. Journal of Clinical Endocrinology and Metabolism, 90, 1992–1997.CrossRefPubMed
36.
go back to reference Boman, U. W., Bryman, I., & Moller, A. (2004). Psychological well-being in women with Turner syndrome: Somatic and social correlates. Journal of Psychosomatic Obstetrics and Gynecology, 25, 211–219.CrossRefPubMed Boman, U. W., Bryman, I., & Moller, A. (2004). Psychological well-being in women with Turner syndrome: Somatic and social correlates. Journal of Psychosomatic Obstetrics and Gynecology, 25, 211–219.CrossRefPubMed
37.
go back to reference Boman, U. W., Bryman, I., Halling, K., & Moller, A. (2001). Women with Turner syndrome: Psychological well-being, self-rated health and social life. Journal of Psychosomatic Obstetrics Gynecology, 22(2), 113–122.CrossRefPubMed Boman, U. W., Bryman, I., Halling, K., & Moller, A. (2001). Women with Turner syndrome: Psychological well-being, self-rated health and social life. Journal of Psychosomatic Obstetrics Gynecology, 22(2), 113–122.CrossRefPubMed
38.
go back to reference Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009). When does it make sense to perform a meta-analysis?, in introduction to meta-analysis. Chichester: Wiley. Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009). When does it make sense to perform a meta-analysis?, in introduction to meta-analysis. Chichester: Wiley.
39.
go back to reference Higgins, J.P.T, & Green, S. (Eds.)., Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://handbook.cochrane.org. Higgins, J.P.T, & Green, S. (Eds.)., Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http://​handbook.​cochrane.​org.
40.
go back to reference Okada, Y. (1994). The quality of life of Turner women in comparison with grown-up GH-deficient women. Endocrine Journal, 41(4), 345–354.CrossRefPubMed Okada, Y. (1994). The quality of life of Turner women in comparison with grown-up GH-deficient women. Endocrine Journal, 41(4), 345–354.CrossRefPubMed
Metagegevens
Titel
Systematic review of quality of life in Turner syndrome
Auteurs
Carolina Trombeta Reis
Maíra Seabra de Assumpção
Gil Guerra-Junior
Sofia Helena Valente de Lemos-Marini
Publicatiedatum
09-02-2018
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 8/2018
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-018-1810-y

Andere artikelen Uitgave 8/2018

Quality of Life Research 8/2018 Naar de uitgave